CareLit Fachartikel

The homeobox transcription factor HoxC9, a key regulator of development, suppresses tumourigenicity of neuroblastoma

H Kocak, S Ackermann, B Hero, Y Kahlert, J Theissen, V Ehemann, F Westermann, M Odenthal, A Oberthuer, F Berthold, M Fischer · Klinische Pädiatrie · 2010 · Heft 05

Dokument
1046911
CareLit-ID
Jahr
2010
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Klinische Pädiatrie
Autor:innen
H Kocak, S Ackermann, B Hero, Y Kahlert, J Theissen, V Ehemann, F Westermann, M Odenthal, A Oberthuer, F Berthold, M Fischer
Ausgabe
Heft 05 / 2010
Seiten
–
Erschienen: 2010-05-07 00:00:00
ISSN
0300-8630

Zusammenfassung

Background: This study aimed at elucidating the role of HoxC9 in NB (neuroblastoma) spontaneous regression and differentiation. Methods: HOXC9 expression levels from 476 NB patients were calculated using microarray technology. HOXC9 gene silencing in NB was investigated by aCGH and methylation analysis. The molecular function of HoxC9 was investigated using a Tet-inducible expression system. The effect of HoxC9 on in vivo tumourigenicity was analysed in NB xenograft models. Results: HOXC9 down-regulation is significantly associated with unfavourable prognostic markers, unfavourable gene expression-based classifi…

Schlagworte

Apoptosis After Klinische Pädiatrie